Chenggang Yuan

Korla, 841000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Gallic acid attenuates the malignant phenotype of prostate cancer cells by antagonizing NF-κB/KLF7/L1CAM expression.

Gallic acid attenuates the malignant phenotype of prostate cancer cells by antagonizing NF-κB/KLF7/L1CAM expression.

Journal: Chinese medical journal

Published: April 24, 2026

Adipose tissue-derived microRNA-450a-5p induces type 2 diabetes mellitus by downregulating DUSP10.

Adipose tissue-derived microRNA-450a-5p induces type 2 diabetes mellitus by downregulating DUSP10.

Journal: Molecular biomedicine

Published: June 20, 2024

Palmitic acid-activated GPRs/KLF7/CCL2 pathway is involved in the crosstalk between bone marrow adipocytes and prostate cancer.

Palmitic acid-activated GPRs/KLF7/CCL2 pathway is involved in the crosstalk between bone marrow adipocytes and prostate cancer.

Journal: BMC cancer

Published: March 31, 2023

Hepatic Glucose Metabolism Disorder Induced by Adipose Tissue-Derived miR-548ag via DPP4 Upregulation.

Hepatic Glucose Metabolism Disorder Induced by Adipose Tissue-Derived miR-548ag via DPP4 Upregulation.

Journal: International journal of molecular sciences

Published: January 06, 2023

Stress-inducible IL-6 is regulated by KLF7 in brown adipocytes.

Stress-inducible IL-6 is regulated by KLF7 in brown adipocytes.

Journal: Heliyon

Published: December 01, 2022

miR-548ag functions as an oncogene by suppressing MOB1B in the development of obesity-related endometrial cancer.

miR-548ag functions as an oncogene by suppressing MOB1B in the development of obesity-related endometrial cancer.

Journal: Cancer science

Published: July 24, 2022

Caprylic Acid (FFA C8:0) promotes the progression of prostate cancer by up-regulating G protein-coupled receptor 84/ Krüppel-like factor 7.

Caprylic Acid (FFA C8:0) promotes the progression of prostate cancer by up-regulating G protein-coupled receptor 84/ Krüppel-like factor 7.

Journal: BMC cancer

Published: July 21, 2022

miR-4431 targets TRIP10/PRKD1 and impairs glucose metabolism.

miR-4431 targets TRIP10/PRKD1 and impairs glucose metabolism.

Journal: Journal of diabetes investigation

Published: August 31, 2021

Showing 1-8 of 8

Last Updated: 09/26/2026